The Prevalence and Risk Factors of Storage Urinary Symptoms in Symptomatic COVID-19 Patients Who were Treated in Cohort Ward and Field Hospital

Abstract

Objective: The primary aim of this study was to focus on the prevalence of storage symptoms in COVID-19 patients and the factors associated with those symptoms. Material and Methods: We collected the data of COVID-19 patients who were admitted to the cohort ward, ICU and field hospital of Thammasat University Hospital, Thailand, between May and June 2021. Patients answered online survey questions and undertook urinalysis by urine dipstick test. The online survey questions related to symptoms of COVID-19 infection, number of daytime voiding, nocturia, frequency and urgency symptom during COVID-19 infection, OABSS and ICIQ-LUTS in the part of storage symptoms subscale. Results: There were 136 COVID-19 patients who met with the eligible criteria and were willing to participate in the study. Patients who had storage symptoms totaled 61 (44.85%) and had average daytime frequency, nocturia and proportion of urgency higher than no storage symptom group (5.9 VS 3.8, 2.0 VS 1.0 and 67.21% VS 6.67% (p-value <0.001), respectively). The OABSS and ICIQ storage subscale in the storage symptoms group were higher than normal group, 3.2 VS 0.9 and 4.5 VS 1.7 (p-value < 0.001), respectively. Conclusion: Our study demonstrated that the SARS-CoV-2 virus infection is associated with abnormal storage symptoms which include frequency, urgency and nocturia. The storage symptoms may be associated with the severity of COVID-19 disease.

Keywords

• storage symptoms
• covid-19
• sars-cov-2 virus
• viral cystitis